BindingDB logo
myBDB logout

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
14971900 5 Synthesis of 2',5'-dideoxy-2-fluoroadenosine and 2',5'-dideoxy-2,5'-difluoroadenosine: potent P-site inhibitors of adenylyl cyclase.EBI National Institute of Diabetes and Digestive and Kidney Diseases
8691441 19 Topographical amino acid substitution in position 10 of glucagon leads to antagonists/partial agonists with greater binding differences.EBI University of Arizona
1973733 17 Conformational analysis and structure-activity relationships of selective dopamine D-1 receptor agonists and antagonists of the benzazepine series.EBI Royal Danish School of Pharmacy
12747789 29 Metal coordination-based inhibitors of adenylyl cyclase: novel potent P-site antagonists.EBI Millennium Pharmaceuticals, Inc.
12372508 20 Hydroxamate based inhibitors of adenylyl cyclase. Part 2: the effect of cyclic linkers on P-site binding.EBI Millennium Pharmaceuticals, Inc.
12372507 30 Hydroxamate based inhibitors of adenylyl cyclase. Part 1: the effect of acyclic linkers on P-site binding.EBI Millennium Pharmaceuticals, Inc.
10937732 15 6-Bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists.EBI NPS Allelix Corp.
8642555 11 (Aminoalkyl)indole isothiocyanates as potential electrophilic affinity ligands for the brain cannabinoid receptor.EBI National Institute of Diabetes and Digestive and Kidney Diseases
7914538 9 Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist.EBI Purdue University
7636869 11 Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors.EBI Purdue University